Alterations in cerebral dopamine function caused by administration ofcis- ortrans-flupenthixol for up to 18 months

[1]  J. Waddington,et al.  Sequelae of 6 months continuous administration of cis(Z)-and trans(E)-flupenthixol in the rat. , 1981, European journal of pharmacology.

[2]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.

[3]  C. Marsden,et al.  Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. , 1980, European journal of pharmacology.

[4]  C. Marsden,et al.  Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration. , 1980, European journal of pharmacology.

[5]  C. Marsden,et al.  Changes in dopamine-mediated behaviour during one year's neuroleptic administration. , 1979, European journal of pharmacology.

[6]  A J Cross,et al.  Change in the charactertistics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: effects of buffer washing of membranes. , 1979, Life sciences.

[7]  J. Leysen,et al.  Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas. , 1979, Biochemical pharmacology.

[8]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[9]  J. Hyttel.  A comparison of the effect of neuroleptic drugs on the binding of 3H-haloperidol and 3H-cis(Z)-flupenthixol and on adenylate cyclase activity in rat striatal tissue in vitro , 1978 .

[10]  P. Seeman,et al.  Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. , 1977, Life sciences.

[11]  B. Scatton.  Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. , 1977, European journal of pharmacology.

[12]  M. Baudry,et al.  Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies , 1977, Brain Research.

[13]  J. Korf,et al.  RAPID CONCURRENT AUTOMATED FLUORIMETRIC ASSAY OF NORADRENALINE, DOPAMINE, 3, 4‐DIHYDROXYPHENYLACETIC ACID, HOMOVANILLIC ACID AND 3‐METHOXYTYRAMINE IN MILLIGRAM AMOUNTS OF NERVOUS TISSUE AFTER ISOLATION ON SEPHADEX G10 , 1977, Journal of neurochemistry.

[14]  S. Snyder,et al.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.

[15]  S. Snyder,et al.  Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. , 1976, Molecular pharmacology.

[16]  R. Baldessarini,et al.  Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. , 1974, Neuropharmacology.

[17]  L. Iversen,et al.  The Action of Neuroleptic Drugs on Dopamine-Stimulated Adenosine Cyclic 3',5'-Monophosphate Production in Rat Neostriatum and Limbic Forebrain , 1974 .

[18]  Richard J. Miller,et al.  Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism , 1974, Nature.

[19]  M. Baggiolini,et al.  Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. , 1973, European journal of pharmacology.

[20]  H. Klawans.  The pharmacology of tardive dyskinesias. , 1973, The American journal of psychiatry.

[21]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Sharman,et al.  The effect of tropolone on the formation of 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the brain of the mouse , 1969, British journal of pharmacology.

[23]  R. Laverty,et al.  THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES. , 1965, British journal of pharmacology and chemotherapy.

[24]  C. Niemegeers,et al.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS. , 1965, Arzneimittel-Forschung.

[25]  A. Randrup,et al.  ADRENERGIC MECHANISMS AND AMPHETAMINE INDUCED ABNORMAL BEHAVIOUR. , 2009, Acta pharmacologica et toxicologica.

[26]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.